GLPwatch
Trials (2167)
Page 10 of 37.
- Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
- A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
- Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial
- Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health
- A Study of LY3437943 in Participants With Impaired and Normal Liver Function
- Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease
- A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland
- A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
- Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
- Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
- Comparison of Three Liraglutide Formulations in Healthy Volunteers
- Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
- Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
- A Study of Multiple Doses of LY3305677 in Healthy Participants
- A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together
- A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
- A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
- Myocardial Protection of Exenatide in AMI
- Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
- Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
- A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
- A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
- TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
- Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
- Exenatide for Smoking Cessation and Prevention of Weight Gain
- A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
- A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
- A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
- Pre-approval Expanded Access of Retatrutide (LY3437943)
- A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
- A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
- Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
- A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
- Mechanisms of Semaglutide Therapy in Heart Failure Patients
- A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
- GLP-1s in Hip and Knee Arthroplasty
- A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
- Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
- New Triple Therapy in Newly Diagnosed Type 2 Diabetes
- The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
- Pharmacology of Exenatide in Pediatric Sepsis
- Incretin-based Therapy in Late Preclinical Type 1 Diabetes
- A Study in Participants With Type 2 Diabetes Mellitus
- A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
- Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
- Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy
- A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
- Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
- Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice
- Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
- A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
- Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects